MedPath

clarithromycin

CLARITHROMYCIN EXTENDED-RELEASE TABLETS, USP

Approved
Approval ID

d9db2fd3-a668-4d37-9082-18f6ceb8c3cb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 2, 2012

Manufacturers
FDA

Dispensing Solutions, Inc.

DUNS: 066070785

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

clarithromycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66336-429
Application NumberANDA065145
Product Classification
M
Marketing Category
C73584
G
Generic Name
clarithromycin
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 2, 2012
FDA Product Classification

INGREDIENTS (11)

GLYCERYL MONOSTEARATEInactive
Code: 230OU9XXE4
Classification: IACT
CLARITHROMYCINActive
Quantity: 500 mg in 1 1
Code: H1250JIK0A
Classification: ACTIB
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC ANHYDROUSInactive
Code: KH7I04HPUU
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
POLYETHYLENE GLYCOL 3000Inactive
Code: SA1B764746
Classification: IACT
POLYVINYL ALCOHOLInactive
Code: 532B59J990
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

clarithromycin - FDA Drug Approval Details